Skip to content

Walking training in intermittent claudication: physiological responses assessed at rest and after maximal exercise

Walking training in intermittent claudication: functional, hemodynamic, autonomic, inflammatory, oxidative stress and genetic regulatory responses measured at rest and after an acute exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3pq58k
Enrollment
Unknown
Registered
2017-03-24
Start date
2014-08-04
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Claudication

Interventions

Control intervention: 15 men with intermittent claudication will undergo for 12 weeks and twice a week, 30 minutes of stretching classes. Walking training intervention: 15 men with intermittent claudi
Other
F01.145.632

Sponsors

Escola de Educação Física e Esporte da Universidade de São Paulo
Lead Sponsor
Ambulatório de Claudicação Intermitente do Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo
Collaborator
Programa de Promoção de Envelhecimento Saudável do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Collaborator

Eligibility

Sex/Gender
Male
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Men; Age between 50 and 80 years; Ankle-brachial index < 0.90 at rest in 1 or 2 legs; Patients with Fontaine stage II symptoms; Able to walk for at least 2 min at 3.2 km/h on a treadmill; Not users of peripheral vasodilators, clopidogrel, beta blockers or nondihydropyridine calcium channel blockers.

Exclusion criteria

Exclusion criteria: Presence of muscle or skeletal disorders that precludes exercise execution; systolic and/or diastolic, respectively, greater than 140 and 90 mmHg; obesity level II or greater; Presence of complex arrhythmias and/ or ischemia during exercise

Design outcomes

Primary

MeasureTime frame
Reduction of the oxidative stress and systemic inflammation measured by lipid peroxidation and interleukin-6 using ELISA Kits, with minimal reduction of 1.08 nmol/ml and 0.55 nmol/ml, respectively, between initial and final evaluations.

Secondary

MeasureTime frame
Reduction of the oxidative stress and muscle inflammation evaluated by catalase increase and intercellular adhesion molecule decrease, respectively, evaluated by genic expression, with minimal increase of 0.07 arbitrary units and reduction of 32.8 arbitrary units, respectively, between initial and final evaluations; Blood pressure decrease verified by auscultatory technique with a minimal reduction of 4 mmHg between initial and after assessments; Heart rate decrease assessed by electrocardiogram with a minimal reduction of 4 bpm between the beginning and end of the study; improve of cardiac and vasomotor autonomic modulation verified by the increase of heart rate modulation and decrease of blood pressure modulation assessed by spectral analysis technique.

Countries

Brazil

Contacts

Public ContactClaudia Forjaz

Escola de Educação Física e Esporte da Universidade de São Paulo

cforjaz@usp.br+55(11)3091-3136

Outcome results

None listed

Source: REBEC (via WHO ICTRP)